Nude mice bearing subcutaneous U87MG.∆EGFR xenografts were treated with nimotuzumab and/or TMZ, and were sacrificed after the first week of treatment (6 days after the start of treatment) to prepare tumor lysates to examine EGFR status of the tumor cells. Here, EGFR is linked to neoplasm.